LBCL: CAR T Benefits Both Young and Old

Older adults with relapsed/refractory large B-cell lymphoma treated with CD19-directed CAR T-cell therapy have similar survival outcomes to younger patients.
MDedge News

source https://www.medscape.com/s/viewarticle/lbcl-car-t-benefits-both-young-and-old-2024a1000dwo?src=rss